FGFR3 mutation causes abnormal membranous ossification in achondroplasia

Human Molecular Genetics

Volumn 23, Issue 11, 2014, Pages 2914-2925

  Di Rocco, Federico ^a,b   Duplan, Martin Biosse ^a,c   Heuzé, Yann ^d   Kaci, Nabil ^a   Komla Ebri, Davide ^a   Munnich, Arnold ^a   Mugniery, Emilie ^a   Benoist Lasselin, Catherine ^a   Legeai Mallet, Laurence ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Paris 5 Descartes University EA 2496 U F R of Odontology   (France)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3;

ACHONDROPLASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALVARIA; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; CRANIOFACIAL SYNOSTOSIS; DWARFISM; EMBRYO; ENCHONDRAL OSSIFICATION; FRONTAL BONE; GAIN OF FUNCTION MUTATION; HUMAN; INFANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKULL BASE; ANATOMY AND HISTOLOGY; ANIMAL; CARTILAGE CELL; CYTOLOGY; EMBRYOLOGY; ENZYMOLOGY; FEMALE; GENETICS; HETEROTOPIC OSSIFICATION; MALE; METABOLISM; MISSENSE MUTATION; PATHOLOGY; SKULL; TRANSGENIC MOUSE;

ACHONDROPLASIA; ANIMALS; CHONDROCYTES; FEMALE; HUMANS; INFANT; MALE; MICE; MICE, TRANSGENIC; MUTATION, MISSENSE; OSSIFICATION, HETEROTOPIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SKULL;

EID: 84899963836     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu004     Document Type: Article

References (52)

1. Naski, M.C., Wang, Q., Xu, J. and Ornitz, D.M. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet., 13, 233-237.
2. Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.M., Maroteaux, P., Le Merrer, M. and Munnich, A. (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature, 371, 252-254.
3. Shiang, R., Thompson, L.M., Zhu, Y.Z., Church, D.M., Fielder, T.J., Bocian, M., Winokur, S.T. and Wasmuth, J.J. (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell, 78, 335-342.
4. Placone, J. and Hristova, K. (2012) Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET. PLoS ONE, 7, e46678.
5. Rousseau, F., el Ghouzzi, V., Delezoide, A.L., Legeai-Mallet, L., Le Merrer, M., Munnich, A. and Bonaventure, J. (1996) Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum. Mol. Genet., 5, 509-512.
6. Muenke, M., Gripp, K.W., McDonald-McGinn, D.M., Gaudenz, K., Whitaker, L.A., Bartlett, S.P., Markowitz, R.I., Robin, N.H., Nwokoro, N., Mulvihill, J.J. et al. (1997) A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am. J. Hum. Genet., 60, 555-564.
7. Ibrahimi, O.A., Zhang, F., Eliseenkova, A.V., Linhardt, R.J. and Mohammadi,M.(2004) Proline to arginine mutations inFGFreceptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Hum. Mol. Genet., 13, 69-78.
8. Lajeunie, E., El Ghouzzi, V., Le Merrer, M., Munnich, A., Bonaventure, J. and Renier, D. (1999) Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation. J. Med. Genet., 36, 9-13.
9. Meyers, G.A., Orlow, S.J., Munro, I.R., Przylepa, K.A. and Jabs, E.W. (1995) Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat. Genet., 11, 462-464.
10. Chen, F., Sarabipour, S. and Hristova, K. (2013) Multiple consequences of a single amino acid pathogenicRTKmutation: theA391Emutation inFGFR3. PLoS ONE, 8, e56521.
11. Marie, P.J., Miraoui, H. and Severe, N. (2012) FGF/FGFR signaling in bone formation: progress and perspectives. Growth Factors (Chur, Switzerland), 30, 117-123.
12. Laurita, J., Koyama, E., Chin, B., Taylor, J.A., Lakin, G.E., Hankenson, K.D., Bartlett, S.P. and Nah, H.D. (2011) The Muenke syndrome mutation (FgfR3(P244R)) causes cranial base shortening associated with growth plate dysfunction and premature perichondrial ossification in murine basicranial synchondroses. Dev. Dyn., 240, 2584-2596.
13. Twigg, S.R., Healy, C., Babbs, C., Sharpe, J.A., Wood, W.G., Sharpe, P.T., Morriss-Kay, G.M. and Wilkie, A.O. (2009) Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome. Dev. Dyn., 238, 331-342.
14. Mansour, S.L., Twigg, S.R., Freeland, R.M., Wall, S.A., Li, C. and Wilkie, A.O. (2009) Hearing loss in a mouse model of Muenke syndrome. Hum. Mol. Genet., 18, 43-50.
15. Naski, M.C., Colvin, J.S., Coffin, J.D. and Ornitz, D.M. (1998) Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development, 125, 4977-4988.
16. Iwata, T., Chen, L., Li, C., Ovchinnikov, D.A., Behringer, R.R., Francomano, C.A. and Deng, C.X. (2000) A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum. Mol. Genet., 9, 1603-1613.
17. Segev, O., Chumakov, I., Nevo, Z., Givol, D., Madar-Shapiro, L., Sheinin, Y., Weinreb,M. and Yayon, A. (2000) Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. Hum. Mol. Genet., 9, 249-258.
18. Pannier, S., Couloigner, V., Messaddeq, N., Elmaleh-Berges, M., Munnich, A., Romand, R. and Legeai-Mallet, L. (2009) Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia. Biochim. Biophys. Acta, 1792, 140-147.
19. Jonquoy, A., Mugniery, E., Benoist-Lasselin, C., Kaci, N., Le Corre, L., Barbault, F., Girard, A.L., Le Merrer, Y., Busca, P., Schibler, L. et al. (2012) A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain of function Fgfr3 mouse model. Hum. Mol. Genet., 21, 841-851.
20. Mugniery, E., Dacquin, R., Marty, C., Benoist-Lasselin, C., de Vernejoul, M.C., Jurdic, P., Munnich, A., Geoffroy,V. and Legeai-Mallet, L. (2012)An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth. Hum. Mol. Genet., 21, 2503-2513.
21. Lorget, F., Kaci, N., Peng, J., Benoist-Lasselin, C., Mugniery, E., Oppeneer, T., Wendt, D.J., Bell, S.M., Bullens, S., Bunting, S. et al. (2012) Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia. Am. J. Hum. Genet., 91, 1108-1114.
22. Horton, W.A., Hall, J.G. and Hecht, J.T. (2007) Achondroplasia. Lancet, 370, 162-172.
23. Morriss-Kay,G.M.(2001) Derivation of themammalianskull vault. J. Anat., 199, 143-151.
24. Ridgway, E.B., Wu, J.K., Sullivan, S.R., Vasudavan, S., Padwa, B.L., Rogers, G.F. and Mulliken, J.B. (2011) Craniofacial growth in patients with FGFR3Pro250Arg mutation after fronto-orbital advancement in infancy. J. Craniofac. Surg., 22, 455-461.
25. Arnaud-Lopez, L., Fragoso, R., Mantilla-Capacho, J. and Barros-Nunez, P. (2007) Crouzon with acanthosis nigricans. Further delineation of the syndrome. Clin. Genet., 72, 405-410.
26. Di Rocco, F., Collet, C., Legeai-Mallet, L., Arnaud, E., Le Merrer, M., Hadj-Rabia, S. and Renier, D. (2011) Crouzon syndrome with acanthosis nigricans: a case-based update. Childs Nerv. Syst., 27, 349-354.
27. Nah, H.D., Koyama, E., Agochukwu, N.B., Bartlett, S.P. and Muenke, M. (2012) Phenotype profile of a genetic mouse model for Muenke syndrome. Childs Nerv. Syst., 28, 1483-1493.
28. Heuze, Y., Boyadjiev, S.A., Marsh, J.L., Kane, A.A., Cherkez, E., Boggan, J.E. and Richtsmeier, J.T. (2010) New insights into the relationship between suture closure and craniofacial dysmorphology in sagittal nonsyndromic craniosynostosis. J. Anat., 217, 85-96.
29. Bessenyei, B., Nagy, A., Balogh, E., Novak, L., Bognar, L., Knegt, A.C. and Olah, E. (2013) Achondroplasia with multiple-suture craniosynostosis: a report of a new case of this rare association. Am. J. Med. Genet. A, 161, 2641-2644.
30. Hecht, J.T., Horton, W.A., Reid, C.S., Pyeritz, R.E. and Chakraborty, R. (1989) Growth of the foramen magnum in achondroplasia. Am. J. Med. Genet., 32, 528-535.
31. Doherty, E.S., Lacbawan, F., Hadley, D.W., Brewer, C., Zalewski, C., Kim, H.J., Solomon, B., Rosenbaum, K., Domingo, D.L., Hart, T.C. et al. (2007) Muenke syndrome (FGFR3-related craniosynostosis): expansion of the phenotype and review of the literature. Am. J. Med. Genet. A, 143A, 3204-3215.
32. Rice, D.P., Rice, R. and Thesleff, I. (2003) FGFR mRNA isoforms in craniofacial bone development. Bone, 33, 14-27.
33. Perlyn, C.A., Morriss-Kay, G., Darvann, T., Tenenbaum, M. and Ornitz, D.M. (2006) A model for the pharmacological treatment of crouzon syndrome. Neurosurgery, 59, 210-215; discussion 210-215.
34. Legeai-Mallet, L., Benoist-Lasselin, C., Munnich, A. and Bonaventure, J. (2004) Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias. Bone, 34, 26-36.
35. Sebastian, A., Matsushita, T., Kawanami, A., Mackem, S., Landreth, G.E. and Murakami, S. (2011) Genetic inactivation of ERK1 and ERK2 in chondrocytes promotesbone growth and enlarges the spinal canal. J. Orthop. Res., 29, 375-379.
36. Matsushita, T., Wilcox, W.R., Chan, Y.Y., Kawanami, A., Bukulmez, H., Balmes, G., Krejci, P., Mekikian, P.B., Otani, K., Yamaura, I. et al. (2009) FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway. Hum. Mol. Genet., 18, 227-240.
37. Su, N., Sun, Q., Li, C., Lu, X., Qi, H., Chen, S., Yang, J., Du, X., Zhao, L., He, Q. et al. (2010) Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis. Hum. Mol. Genet., 19, 1199-1210.
38. Chim, H., Manjila, S., Cohen, A.R. and Gosain, A.K. (2011) Molecular signaling in pathogenesis of craniosynostosis: the role of fibroblast growth factor and transforming growth factor-beta. Neurosurg. Focus, 31, E7.
39. Krejci, P., Aklian, A., Kaucka, M., Sevcikova, E., Prochazkova, J., Masek, J.K., Mikolka, P., Pospisilova, T., Spoustova, T., Weis, M. et al. (2012) Receptor tyrosine kinases activate canonical WNT/beta-catenin signaling via MAP kinase/LRP6 pathway and direct beta-catenin phosphorylation. PLoS ONE, 7, e35826.
40. Agochukwu, N.B., Solomon, B.D., Benson, L.J. and Muenke, M. (2013) Talocalcaneal coalition in Muenke syndrome: report of a patient, review of the literature in FGFR-related craniosynostoses, and consideration of mechanism. Am. J. Med. Genet. A, 161A, 453-460.
41. Hatch, N.E. (2010) FGF signaling in craniofacial biological control and pathological craniofacial development. Crit. Rev. Eukaryotic Gene Expression, 20, 295-311.
42. Wilkie, A.O. (1997) Craniosynostosis: genes and mechanisms. Hum. Mol. Genet., 6, 1647-1656.
43. Quarto, N., Behr, B., Li, S. and Longaker, M.T. (2009) Differential FGF ligands and FGFreceptors expression pattern in frontal and parietal calvarial bones. Cells Tissues Organs, 190, 158-169.
44. Georgoulis, G., Alexiou, G. and Prodromou, N. (2011) Achondroplasia with synostosis of multiple sutures. Am. J. Med. Genet. A, 155A, 1969-1971.
45. Karadimas, C., Trouvas, D., Haritatos, G., Makatsoris, C., Dedoulis, E., Velissariou, V., Antoniadi, T., Hatzaki, A. and Petersen, M.B. (2006) Prenatal diagnosis of achondroplasia presenting with multiple-suture synostosis: a novel association. Prenat. Diagn., 26, 258-261.
46. Angle, B., Hersh, J.H. and Christensen, K.M. (1998) Molecularly proven hypochondroplasia with cloverleaf skull deformity: a novel association. Clin. Genet., 54, 417-420.
47. Bellus, G.A., McIntosh, I., Smith, E.A., Aylsworth, A.S., Kaitila, I., Horton, W.A., Greenhaw, G.A., Hecht, J.T. and Francomano, C.A. (1995) A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet., 10, 357-359.
48. Tavormina, P.L., Shiang, R., Thompson, L.M., Zhu, Y.Z., Wilkin, D.J., Lachman, R.S., Wilcox, W.R., Rimoin, D.L., Cohn, D.H. and Wasmuth, J.J. (1995) Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet., 9, 321-328.
49. Barroso, E., Perez-Carrizosa, V., Garcia-Recuero, I., Glucksman, M.J., Wilkie, A.O., Garcia-Minaur, S. and Heath, K.E. (2011) Mild isolated craniosynostosis due to a novel FGFR3 mutation, p.Ala334Thr. Am. J. Med. Genet. A, 155A, 3050-3053.
50. Metzger, D., Clifford, J., Chiba, H. and Chambon, P. (1995) Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. USA, 92, 6991-6995.
51. Rohlf, F.S.D. (1990) Extensions of the Procrustes method for the optimal superimposition of landmarks. Syst. Zool., 39, 40-59.
52. Dryden, I.L. and Mardia, K.V. (1998) Statistical Shape Analysis. Wiley, Chichester, UK.